Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Encapsulated with: Cellulose, Capsule Shell (Gelatin), Magnesium Stearate, Silicon Dioxide
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
Some patients find that timing their larger meals several hours after injection allows them to experience semaglutide's appetite-suppressing effects more clearly
Allo stesso tempo, essenziale mantenere un approccio realistico e basato sulle evidenze: oggi non una terapia disponibile , ma un farmaco sperimentale in fase di studio
Do not change, adjust, or discontinue any medications or prescribed treatments without your physicians guidance and approval
RYBELSUS (semaglutide) tablets (formulation R2) are available as: 1.5 mg: white to light yellow, round shaped debossed with 1.5 on one side and novo on the other side
US$ 22.02
US$ 27.94
US$ 22.76
